91 related articles for article (PubMed ID: 9185756)
1. Germ-line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma.
Chaubert P; Gayer R; Zimmermann A; Fontolliet C; Stamm B; Bosman F; Shaw P
Hepatology; 1997 Jun; 25(6):1376-81. PubMed ID: 9185756
[TBL] [Abstract][Full Text] [Related]
2. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors.
Chaubert P; Guillou L; Kurt AM; Bertholet MM; Metthez G; Leisinger HJ; Bosman F; Shaw P
Am J Pathol; 1997 Sep; 151(3):859-65. PubMed ID: 9284835
[TBL] [Abstract][Full Text] [Related]
3. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
Chen TC; Hsieh LL; Kuo TT; Ng KF; Wu Chou YH; Jeng LB; Chen MF
Anticancer Res; 2000; 20(3A):1621-6. PubMed ID: 10928081
[TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of p16INK4 in hepatocellular carcinoma.
Hui AM; Sakamoto M; Kanai Y; Ino Y; Gotoh M; Yokota J; Hirohashi S
Hepatology; 1996 Sep; 24(3):575-9. PubMed ID: 8781327
[TBL] [Abstract][Full Text] [Related]
6. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
[TBL] [Abstract][Full Text] [Related]
7. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
[TBL] [Abstract][Full Text] [Related]
9. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC
Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830
[TBL] [Abstract][Full Text] [Related]
10. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
[TBL] [Abstract][Full Text] [Related]
11. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
12. Informative MspI polymorphism adjacent to exon 3 of the p16INK4 (MTS1) gene.
Chaubert P; Shaw P; Pillet N
Mol Cell Probes; 1996 Dec; 10(6):467-8. PubMed ID: 9025085
[No Abstract] [Full Text] [Related]
13. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of c-myc gene amplification, MTS1/p16 gene alternation, and HBV infection in human hepatocellular carcinoma].
Zhang J; Wang K; Cong S; Qiu F; Wang X; Wang P
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):294-6. PubMed ID: 11676877
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
16. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.
Duro D; Bernard O; Della Valle V; Berger R; Larsen CJ
Oncogene; 1995 Jul; 11(1):21-9. PubMed ID: 7624129
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
19. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
[TBL] [Abstract][Full Text] [Related]
20. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
